SEROLOGICALS CORP·4

Jun 23, 5:30 PM ET

OCONNELL DESMOND H JR 4

4 · SEROLOGICALS CORP · Filed Jun 23, 2005

Insider Transaction Report

Form 4
Period: 2005-06-21
Transactions
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2005-06-21$4.81/sh+12,500$60,16378,678.77 total
  • Sale

    Common Stock, $0.01 par value

    2005-06-21$20.70/sh12,500$258,75066,178.77 total
  • Conversion

    Stock Option

    2005-06-2112,500120,466 total
    Exercise: $4.81From: 2003-11-30Exp: 2005-11-12Common Stock, $0.01 par value (12,500 underlying)
Footnotes (2)
  • [F1]This represents a transaction executed under a stock trading program in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, which permist participating Company executives and Board members to adopt pre-arranged stock trading plans to sell a portion of their Company stock over time.
  • [F2]Includes 15,478.77 rights to shares of Common Stock earned as a result of deferring fees earned while serving as a Director of the Company. The shares are issuable upon the last day of service as a Director of the Company.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_90726

    POA DOCUMENT